Part-Time
Child Life Specialist 1
PRN
Posted on 9/9/2026
Cincinnati Children’s Hospital and Medical Center
10,001+ employees
Pediatric hospital, research, and medical education
Compensation Overview
$53.7k - $67.1k/yr
United States + 1 more
More locations: Cincinnati, OH, USA
In Person
Bachelor's
 Medical, Clinical & Veterinary |
|---|
Get referred to Cincinnati Children’s Hospital and Medical Center
See people who can refer or advise you
- Bachelor's degree in a related field.
- 0+ years of work experience in a related job discipline.
- Completion of a child life internship under the supervision of a certified Child Life Specialist.
- Obtain Certified Child Life Specialist (CCLS) certification within one year of hire.
- Perform psychosocial assessments of patients and families to identify strengths, concerns, and needs and establish short- and long-term goals.
- Facilitate family involvement and support patients and families in adjusting to injury, diagnosis, chronic illness, or disability.
- Identify and advocate for the needs of patients and families within the healthcare system and community.
- Evaluate the effectiveness of child life interventions and modify interventions based on results.
- Report suspected abuse and neglect as mandated for investigation.
- Implement intervention strategies for individual patients and families, review goals, and revise them as appropriate.
- Conduct post-procedural assessments and interventions and promote and support pain management.
- Document services and interventions provided, participate in patient care conferences and rounds, and follow up on referrals in a timely manner.
- Support and participate in process-improvement activities and evidence-based care or professional inquiry.
- Contribute to the advancement of professional standards within the division, hospital, and community.
- Orient and supervise volunteers and contribute to the education and training of students and other professionals.
- Share knowledge with peers, remain current in the professional field, complete continuing education, and integrate new knowledge and skills into practice.
- Submit supply requests according to departmental guidelines.
- Maintain organized, safe, and professional work areas for employees, patients, and families.
- Identify potential problems, remove barriers, assume ownership of problems, and resolve issues at the lowest appropriate level.
- Manage time, priorities, workload, and resources to provide a consistent volume of work.
- Complete special assignments and projects while maintaining regular workflow.
- Identify and implement new work procedures to increase personal productivity.
- Complete required daily and weekly information exchanges and documentation according to division guidelines.
- Engage in multidisciplinary teamwork, participate in problem solving and collegial learning, and pursue best practices.
- Address conflicts directly, constructively, and tactfully and support cooperation, respect, and trust within the team.
- Respond to the day-to-day needs of coworkers and the division.
- Provide education, preparation, procedural support, and play to meet the psychosocial needs of infants, children, adolescents, and young adults and their families.
Cincinnati Children’s Hospital Medical Center provides pediatric healthcare ranging from routine checkups to treatments for rare, complex conditions. The center operates by integrating clinical care with a research-based education system that trains over 600 medical residents and fellows annually. It distinguishes itself from other providers by serving as a major academic department for the University of Cincinnati, combining large-scale medical training with active scientific research. The organization's goal is to improve child health outcomes through a combination of specialized patient care, medical discovery, and the education of future pediatric professionals.
Company Size
10,001+
Company Stage
Grant
Total Funding
$18.4M
Headquarters
Cincinnati, Ohio
Founded
1883
Get referred to Cincinnati Children’s Hospital and Medical Center
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 31, 2026 NHLBI renewed $38.4 million, preserving long-duration research funding.
- June 11, 2026 ARIA selected Cincinnati Children’s for a $17.25 million autism network.
- August 5, 2026 Carrie Romano’s promotion reinforces nursing continuity and workforce stability.
What critics are saying
- Howard Saal lawsuits since August 2025 threaten trust, referrals, and settlement costs.
- The Saal case names Cincinnati Children’s, risking discovery into safeguarding failures through 2026.
- Any patient-safety scandal can erode its pediatric brand faster than competitors can recruit.
What makes Cincinnati Children’s Hospital and Medical Center unique
- Cincinnati Children’s runs NIH-scale genomics programs, including $38.4 million B2B CHANGE through 2032.
- It packages specialty care with protocols, like SKMC’s 2026 SDR pathway.
- Parkview’s June 2026 joint operating agreement extends Cincinnati Children’s care model regionally.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
Tuition Reimbursement
Employee Discounts
Wellness Program
Relocation Assistance
Company News
Sheikh Khalifa Medical City launches integrated Paediatric spasticity programme. ABU DHABI, (UrduPoint / Pakistan Point News / WAM - 02nd Sep, 2026) SEHA, a subsidiary of PureHealth, announced that SEHA's Sheikh Khalifa Medical City (SKMC) has successfully performed its first Selective Dorsal Rhizotomy (SDR) procedure in collaboration with Cincinnati Children's, marking the launch of a comprehensive spasticity management programme for children in the UAE. SDR is an advanced specialised neurosurgical intervention used to reduce lower-limb spasticity in children with spastic diplegia associated with cerebral palsy. The programme at SKMC is being implemented in line with the full clinical pathway followed by Cincinnati Children's, including careful patient selection and preoperative assessment, the surgical procedure, postoperative care, and long-term rehabilitation. The programme is built around a multidisciplinary model that extends beyond surgery itself. Children considered suitable for SDR undergo careful evaluation, followed by surgery and a structured rehabilitation pathway that may continue for up to one year. This includes intensive physiotherapy, regular reassessment, and coordinated follow-up designed to support mobility, function, and long-term clinical outcomes. Dr. Arun Babu Rajeswaran, consultant Neurosurgeon and Division Chief of Neurosurgery at SEHA's SKMC, said, "SDR is not a standalone surgery, but part of a carefully structured treatment programme that begins with rigorous patient selection and continues through long-term rehabilitation. It can make a meaningful difference in mobility and quality of life in children who are good candidates for the procedure. "Through our collaboration with Cincinnati Children's, we have been able to implement a comprehensive pathway that brings advanced spasticity management closer to families in the UAE." Dr. Francesco T. Mangano, Division Chief of Paediatric Neurosurgery at Cincinnati Children's, said, "This collaboration brings specialised SDR evaluation, surgery, and rehabilitation closer to children and families in a region where access to this level of care has previously required travel abroad. By working together to implement a complete clinical pathway, the teams at Sheikh Khalifa Medical City and Cincinnati Children's are helping ensure availability to world-class care closer to home." Facebook Twitter Reddit Pinterest Whatsapp
Major AI, robotics and biotech funding rounds and market signals August 2026. In August 2026 a series of large capital raises, insider purchases and industry forecasts highlighted growing investment in AI infrastructure, general-purpose robotics and AI-enabled biotech. Compiled automatically from the sources listed below and checked against Hyperuranios' own capital and research data. Every figure here traces to a linked source. Artificial Intelligence. Alibaba priced a placement of 710 million new shares at HK$112.70 each, raising roughly HK$80 billion, with the net proceeds earmarked for full-stack AI capabilities and infrastructure. Shortly after, Jack Ma bought more than HK$600 million of the company's Hong Kong-listed shares, while co-founder Joe Tsai and CEO Eddie Wu purchased about HK$202 million combined, signalling senior confidence despite the 8.4% discount to the prior close and the dilution impact [3]. Semiconductor analyst Dylan Patel projected that OpenAI and Anthropic will dominate the majority of usable global AI compute by the end of 2028. He noted each lab controlled about 2 GW of compute at the start of 2026 and expects that to rise to 5 GW by year-end, giving them 40-50% of incremental compute next year and 70-80% by 2028, driven by highly profitable inference operations that fund further model training [4]. AM Intelligence (AMI) announced an order for 9,000 Nvidia Vera Rubin chips as it builds a 5 GW global AI data-centre network, planning to deploy 200 MW of capacity over the next 18 months. The expansion is backed by $3 billion of combined debt and equity financing, aimed at serving global AI customers and model-training workloads [5]. Robotics. Robotics startup Generalist raised an additional nearly $200 million in an extension of its Series B round, bringing total Series B funding to $600 million and lifting its post-money valuation to $3 billion. The round was led by 8VC and followed a June $400 million raise led by Radical Ventures at a $2 billion valuation. Founded by former Google DeepMind researchers Pete Florence and Andy Zeng and ex-Boston Dynamics engineer Andrew Barry, Generalist is developing a Gen 1.5 foundation model that teaches robots new tasks from video clips as short as three to twelve seconds [2][1]. XPeng's robotics unit, Dogotix, secured more than $900 million in a financing round that valued the business at over $6.3 billion post-money, with a pre-money valuation of $5 billion. The round was led by IDG Capital, included Gaorong Ventures, and counted Tencent and Alibaba as strategic investors. Proceeds will fund hardware and software R&D for the IRON humanoid robot, data collection, Physical AI model training, mass-production facilities and international expansion, targeting a production rate of 1,000 units per month by the end of 2026 and commercial deliveries in 2027 [6][7]. Genetic engineering. Airway Therapeutics closed a $50 million equity round comprising $26 million from a prior SAFE and $24 million from a Series E-2 financing, with roughly 94% of existing investors participating, including Cincinnati Children's and a syndicate of large family offices. The capital will primarily support the Phase 2b/3 trial of zelpultide alfa for preventing bronchopulmonary dysplasia in very preterm infants, as well as associated CMC and analytical activities required for late-stage development [8].
Airway Therapeutics has closed a $50 million equity round to advance late-stage development of zelpultide alfa, a novel recombinant human surfactant protein designed to prevent bronchopulmonary dysplasia in very preterm infants. The round comprises $26 million from previous SAFE financing and $24 million from the Series E-2 round. Approximately 94% of existing investors participated in the Series E-2 round, including Cincinnati Children's and several family offices. The proceeds will primarily support completion of the ongoing Phase 2b portion of the Phase 2b/3 clinical trial, plus associated chemistry, manufacturing and analytical work. The company expects interim analysis results by the end of Q2 2027. Currently, no approved preventive therapies exist for bronchopulmonary dysplasia.
2026 pre-swim research update. August 10, 2026 As Team Hydro look forward to the upcoming 2026 Alcatraz swim this Saturday, August 15, Team Hydro is excited to provide an update on its research efforts. Thanks to your generous support, Team Hydro funded three new research grants since its last swim. * Addressing infection as a driver of hydrocephalus worldwide. While most hydrocephalus in the United States develops following a brain hemorrhage, infection remains the leading cause worldwide. Investigators at Yale are partnering with Jinja Regional Referral Hospital in Uganda to strengthen diagnostic capacity for Paenibacillus, a bacterium associated with a rising number of neonatal infections and cases of post-infectious hydrocephalus in East Africa and, more recently, in the United States. The grant supports evaluation of a point-of-care diagnostic assay alongside genomic sequencing to characterize antimicrobial resistance and virulence. Earlier and more accurate diagnosis offers the potential to prevent hydrocephalus before it develops. * Choroid plexus-targeted therapy to reduce cerebrospinal fluid production. Investigators at Cincinnati Children's Hospital are developing a biologic therapy directed at the choroid plexus, the tissue responsible for producing cerebrospinal fluid, in order to reduce the fluid accumulation that characterizes hydrocephalus. Preliminary results have established the feasibility of the approach; this grant supports development of the scalable manufacturing process required to advance toward clinical use. Success would provide a non-surgical alternative to shunt placement and the repeated revision surgeries it often entails. * Focused ultrasound as a non-invasive route for gene delivery. A central obstacle in treating neurological disease is delivering therapies to the appropriate cells within the brain. Investigators at the University of Patras in Greece are evaluating focused ultrasound as a means of delivering gene therapies to the ependymal cells lining the cerebral ventricles. If successful, the approach would allow treatments to be administered without surgical intervention. As Team Hydro support these new grants, Team Hydro continues to work closely with prior grantees, including Dr. Bonnie Blazer-Yost, who now leads the newly established Hydrocephalus Research Center at Indiana University Indianapolis - an effort made possible in part by Team Hydro's early support. Her team's work on non-invasive approaches to hydrocephalus has produced several new publications and earned three competitive awards from the American Physiological Society. For detailed summaries of these - and all other grants Team Hydro has funded to date - see its research page at https://teamhydro.org/its-research/.
Cincinnati Children's names Carrie Romano as chief nurse executive. Aug 05, 2026, 08:00 ET Key Takeaways * Carrie Romano, a Cincinnati Children's nurse leader with more than 36 years of experience, will become chief nurse executive Sept. 6. * The organization is renaming its top nursing position from chief nursing officer to chief nurse executive, underscoring nursing's growing role in enterprise strategy, innovation, workforce development and the future of care. * Romano succeeds Barb Tofani, whose tenure helped advance nursing excellence, quality outcomes and exceptional care for children and families. CINCINNATI, Aug. 5, 2026 /PRNewswire/ - After a national search, Cincinnati Children's has appointed longtime nursing leader Carrie Romano, DNP, RN, as its next chief nurse executive. Romano, who will assume the role Sept. 6, brings more than 36 years of nursing leadership to one of the nation's premier pediatric nursing programs. She succeeds Barb Tofani, MSN, RN, chief nursing officer and senior vice president of Patient Services, who will retire Nov. 2. In addition to the transition, the appointment marks a change in the title of the health system's senior nursing leader. The role previously known as chief nursing officer will become chief nurse executive, reflecting the expanded enterprise leadership responsibilities of the position and the vital role nursing plays in shaping organizational strategy, driving innovation and advancing the future of care. Romano began at Cincinnati Children's as a staff nurse in 1989 and has held roles of increasing responsibility, most recently as vice president of Patient Services, where she provides executive leadership for Ambulatory Services, Care Management and Home Care Services. Throughout her career, she has led initiatives to strengthen quality and safety, expand access to care, advance digital health and telehealth, develop high-performing teams and future leaders, and guide strategic growth across multiple sites of care. "Carrie is an exceptional leader whose vision, experience and unwavering commitment to children and families make her the ideal person to lead our workforce into the future," said Steve Davis, MD, president and chief executive officer of Cincinnati Children's. "She has consistently demonstrated a passion for developing people, advancing innovation and delivering outstanding care. As we continue deepening our commitment to nursing and allied health excellence, I am confident she will further elevate the impact of these essential teams as we work together to improve child health." Romano earned a doctor of nursing in population health leadership and a master's degree in nursing from Xavier University, a bachelor's in nursing from the University of Cincinnati and a diploma in nursing from the Christ Hospital School of Nursing. "I am honored to serve as Cincinnati Children's next chief nurse executive," Romano said. "Nursing and allied health are central to who we are as a health system and to the care we provide every day. I look forward to partnering with colleagues across Cincinnati Children's to support our teams, strengthen care delivery and help shape the future of child health." Cincinnati Children's also celebrates the extraordinary contributions of Tofani, whose leadership helped elevate nursing excellence and earned national recognition, including four consecutive Magnet(R) designations from the American Nurses Credentialing Center. Her retirement marks a distinguished career dedicated to advancing exceptional nursing practice, quality outcomes and care for children and families. About Cincinnati Children's Cincinnati Children's is ranked among the best pediatric health systems in the nation by U.S. News & World Report, including No. 1 in three specialties: Cancer care, Gastroenterology & GI surgery, and Diabetes & Endocrinology. Established in 1883, the academic health system leads the way in healthcare education and pediatric research, where discoveries become innovative treatments and cures that change the outcome for children. All of this is backed by an extraordinary culture that includes over 19,600 team members; Cincinnati Children's ranks No. 1 in Ohio and No. 5 in the nation on the Forbes list of America's Best Employers for Healthcare Professionals. More information: www.Cincinnatichildrens.org SOURCE Cincinnati Children's Hospital Medical Center